Logo Image
News
OncClubAll Oncology NewsClinical Trials in Focus
Media
InsightsMedNews WeekOncChatsOncLive News Network®OncLive TVPeer ExchangePodcastsRapid ReadoutsShorts
Conferences
Conference CoverageConference Listing
Events
Giants of Cancer CareCME/CEScientific InterchangesState of the Science Summit / IPCNational Fellows ForumWebinars
More
Partners
Publications
All PublicationsSupplements
Resources
Consensus ViewpointsOncLive AppInteractive ToolsSponsored
Biomarker Consortium

Subscribe

  • News
  • Media
  • Conferences
  • Events
  • Partners
  • Publications
  • Resources
  • Biomarker Consortium
  • Subscribe
  • AI for Oncology
  • Biosimilars
  • Brain Cancer
  • Breast Cancer
    • HER2+ Breast Cancer
  • CAR T-Cell Therapy
  • Disparities in Cancer Care
  • Gastrointestinal Cancer
    • Pancreatic Cancer
    • Hepatocellular Carcinoma
    • Gastric Cancer
    • Colorectal Cancer
  • Genitourinary Cancers
    • Urothelial Cancer
    • Prostate Cancer
  • Global Oncology
  • Graft-vs-Host Disease
  • Gynecologic Oncology
    • Ovarian Cancer
  • Head & Neck Cancers
  • Hematologic Oncology
    • Chronic Lymphocytic Leukemia
    • Non-Hodgkin Lymphoma
    • Mantle Cell Lymphoma
    • Multiple Myeloma
    • Myeloproliferative Neoplasms
  • Immuno-Oncology
  • Lung Cancer
  • Melanoma & Skin Cancer
  • Oncology Business Management
  • Pediatric Oncology
  • Precision Medicine in Oncology®
  • Sarcomas
  • Supportive Care
Spotlight -
The OncLive Insider app is live!|
CME Opportunities
Advertisement

Expert Perspectives in Metastatic Breast Cancer

EP. 1: Introduction: Impact of Molecular Subtyping in Breast Cancer

February 25th 2015

EP. 2: Role of Genetic Testing in Breast Cancer

February 25th 2015

EP. 3: Pathologist's Role in Genetic Testing for Breast Cancer

February 25th 2015

EP. 4: Reviewing Key Genomic Assays in Breast Cancer

February 25th 2015

EP. 5: Predicting Risk of Recurrence in Breast Cancer

February 25th 2015

EP. 6: Pathology, Oncology Collaboration in Breast Cancer

February 25th 2015

EP. 7: Genetic Tests Offer New Tool for Tumor Assessment

February 25th 2015

EP. 8: Treating ER-Positive De Novo Metastatic Breast Cancer

February 25th 2015

EP. 9: CDK4/6 Inhibition in Metastatic Breast Cancer

February 25th 2015

EP. 10: Endocrine Therapy Resistance in Breast Cancer

February 25th 2015

EP. 11: Role of Bevacizumab in Breast Cancer

February 25th 2015

EP. 12: BOLERO-2: Everolimus Plus Exemestane in Resistant MBC

February 25th 2015

EP. 13: Pertuzumab in HER2-Positive Metastatic Breast Cancer

February 25th 2015

EP. 14: Role of T-DM1 in HER2-Positive Breast Cancer

February 25th 2015

EP. 15: Managing Brain Metastases in Breast Cancer

February 25th 2015

EP. 16: Standard Therapies for Triple-Negative Breast Cancer

February 25th 2015

EP. 17: Chemotherapeutics for Triple-Negative Breast Cancer

February 25th 2015

EP. 18: Future Treatments for Triple-Negative Breast Cancer

February 25th 2015
Advertisement
Advertisement

Trending on OncLive

1

Epcoritamab Plus Lenalidomide/Rituximab Win EU Approval for R/R Follicular Lymphoma

2

Divarasib Outperforms First-Generation KRAS G12C Inhibitors in Phase 3 NSCLC Trial

3

FDA Issues CRL to Orviglance for Liver Metastasis Imaging in Patients With Severe Kidney Impairment

4

Savolitinib Gains NMPA Approval for MET-Amplified Gastric and GEJ Adenocarcinoma

5

Health Canada Green Lights Ropeginterferon Alfa-2b for Polycythemia Vera

  • Advertise
  • About OncLive
  • Editorial Board
  • MJH Life Sciences brands
  • Contact Us
  • Privacy
  • Terms & Conditions
  • Do Not Sell My Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo
Download on Apple
Download on Google Play

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us